Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2026-01-03 @ 4:37 AM
Study NCT ID:
NCT06394661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-23
First Post:
2024-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer
Sponsor:
Organization: